MNPR
Price
$38.41
Change
-$1.84 (-4.57%)
Updated
Feb 24, 11:38 AM (EDT)
Capitalization
245.63M
SHJBF
Price
$1.97
Change
+$0.73 (+58.87%)
Updated
Dec 31 closing price
Capitalization
3.4B
Ad is loading...

MNPR vs SHJBF

Header iconMNPR vs SHJBF Comparison
Open Charts MNPR vs SHJBFBanner chart's image
Monopar Therapeutics
Price$38.41
Change-$1.84 (-4.57%)
Volume$100
Capitalization245.63M
SHANGHAI JUNSHI BIOSCIENCES
Price$1.97
Change+$0.73 (+58.87%)
Volume$150
Capitalization3.4B
MNPR vs SHJBF Comparison Chart
Loading...
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MNPR vs. SHJBF commentary
Feb 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNPR is a Hold and SHJBF is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 24, 2025
Stock price -- (MNPR: $40.25 vs. SHJBF: $1.97)
Brand notoriety: MNPR and SHJBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNPR: 70% vs. SHJBF: 30%
Market capitalization -- MNPR: $245.63M vs. SHJBF: $3.4B
MNPR [@Biotechnology] is valued at $245.63M. SHJBF’s [@Biotechnology] market capitalization is $3.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNPR’s FA Score shows that 0 FA rating(s) are green whileSHJBF’s FA Score has 0 green FA rating(s).

  • MNPR’s FA Score: 0 green, 5 red.
  • SHJBF’s FA Score: 0 green, 5 red.
According to our system of comparison, SHJBF is a better buy in the long-term than MNPR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNPR’s TA Score shows that 3 TA indicator(s) are bullish.

  • MNPR’s TA Score: 3 bullish, 5 bearish.

Price Growth

MNPR (@Biotechnology) experienced а -6.61% price change this week, while SHJBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.06%. For the same industry, the average monthly price growth was -4.97%, and the average quarterly price growth was +1.03%.

Reported Earning Dates

MNPR is expected to report earnings on Nov 08, 2024.

Industries' Descriptions

@Biotechnology (-2.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHJBF($3.4B) has a higher market cap than MNPR($246M). MNPR YTD gains are higher at: 82.955 vs. SHJBF (0.000).
MNPRSHJBFMNPR / SHJBF
Capitalization246M3.4B7%
EBITDA-7MN/A-
Gain YTD82.9550.000-
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash6.02MN/A-
Total Debt0N/A-
TECHNICAL ANALYSIS
Technical Analysis
MNPR
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 20 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Ad is loading...
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL245.55-0.28
-0.11%
Apple
BTC.X96273.920000-303.835940
-0.31%
Bitcoin cryptocurrency
SPY599.94-10.44
-1.71%
SPDR® S&P 500® ETF Trust
GME26.42-0.62
-2.29%
GameStop Corp
TSLA337.80-16.60
-4.68%
Tesla

MNPR and

Correlation & Price change

A.I.dvisor tells us that MNPR and QNCX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MNPR and QNCX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
-1.76%
QNCX - MNPR
27%
Poorly correlated
-3.45%
RAPT - MNPR
26%
Poorly correlated
-0.79%
NEUP - MNPR
25%
Poorly correlated
-3.37%
AGIO - MNPR
25%
Poorly correlated
+4.36%
QRON - MNPR
25%
Poorly correlated
N/A
More

SHJBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SHJBF has been loosely correlated with AUPH. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SHJBF jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHJBF
1D Price
Change %
SHJBF100%
N/A
AUPH - SHJBF
38%
Loosely correlated
+1.28%
UCBJF - SHJBF
30%
Poorly correlated
+1.17%
SRPT - SHJBF
28%
Poorly correlated
-1.96%
QRON - SHJBF
24%
Poorly correlated
N/A
MNPR - SHJBF
21%
Poorly correlated
-1.76%
More